AE, L., GU, H., CH, A., D, B., C, K., TF, O., . . . AJ, S. (2024). Concerns with the new biological research criteria for synucleinopathy - Authors' reply. The Lancet. Neurology, 23(7), 666. https://doi.org/10.1016/S1474-4422(24)00212-6
Chicago Style (17th ed.) CitationAE, Lang, Höglinger GU, Adler CH, Berg D, Klein C, Outeiro TF, Poewe W, Postuma R, and Stoessl AJ. "Concerns with the New Biological Research Criteria for Synucleinopathy - Authors' Reply." The Lancet. Neurology 23, no. 7 (2024): 666. https://doi.org/10.1016/S1474-4422(24)00212-6.
MLA (9th ed.) CitationAE, Lang, et al. "Concerns with the New Biological Research Criteria for Synucleinopathy - Authors' Reply." The Lancet. Neurology, vol. 23, no. 7, 2024, p. 666, https://doi.org/10.1016/S1474-4422(24)00212-6.